These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 7716766)

  • 1. Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone.
    Murakami M; Hosokawa S; Yamada T; Harakawa M; Ito M; Koyama Y; Kimura J; Yoshitake A; Yamada H
    Toxicol Appl Pharmacol; 1995 Apr; 131(2):244-52. PubMed ID: 7716766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The affinity of procymidone to androgen receptor in rats and mice.
    Hosokawa S; Murakami M; Ineyama M; Yamada T; Yoshitake A; Yamada H; Miyamoto J
    J Toxicol Sci; 1993 May; 18(2):83-93. PubMed ID: 8331696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of long-term dietary administration of procymidone, a fungicide with anti-androgenic effects, or the phytoestrogen genistein to rats on the pituitary-gonadal axis and Leydig cell steroidogenesis.
    Svechnikov K; Supornsilchai V; Strand ML; Wahlgren A; Seidlova-Wuttke D; Wuttke W; Söder O
    J Endocrinol; 2005 Oct; 187(1):117-24. PubMed ID: 16214947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of procymidone on reproductive organs and serum gonadotropins in male rats.
    Hosokawa S; Murakami M; Ineyama M; Yamada T; Koyama Y; Okuno Y; Yoshitake A; Yamada H; Miyamoto J
    J Toxicol Sci; 1993 May; 18(2):111-24. PubMed ID: 8331691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of serum luteinizing hormone levels with the induction of Leydig cell tumors in rats by oxolinic acid.
    Yamada T; Nakamura J; Murakami M; Okuno Y; Hosokawa S; Matsuo M; Yamada H
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):146-54. PubMed ID: 7974488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole.
    Fort FL; Miyajima H; Ando T; Suzuki T; Yamamoto M; Hamashima T; Sato S; Kitazaki T; Mahony MC; Hodgen GD
    Fundam Appl Toxicol; 1995 Jul; 26(2):191-202. PubMed ID: 7589908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism.
    Cook JC; Murray SM; Frame SR; Hurtt ME
    Toxicol Appl Pharmacol; 1992 Apr; 113(2):209-17. PubMed ID: 1561629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulatory effect of luteinizing hormone on the development and maintenance of 5 alpha-reduced steroid-producing testicular interstitial cell tumors in Fischer 344 rats.
    Chatani F; Nonoyama T; Sudo K; Miyajima H; Takeyama M; Takatsuka D; Mori H; Matsumoto K
    Anticancer Res; 1990; 10(2A):337-42. PubMed ID: 2189360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iprodione delays male rat pubertal development, reduces serum testosterone levels, and decreases ex vivo testicular testosterone production.
    Blystone CR; Lambright CS; Furr J; Wilson VS; Gray LE
    Toxicol Lett; 2007 Nov; 174(1-3):74-81. PubMed ID: 17931804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of continuous testosterone exposure on spontaneous and cadmium-induced tumors in the male Fischer (F344/NCr) rat: loss of testicular response.
    Waalkes MP; Rehm S; Devor DE
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):40-6. PubMed ID: 9007032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo.
    Nellemann C; Dalgaard M; Lam HR; Vinggaard AM
    Toxicol Sci; 2003 Feb; 71(2):251-62. PubMed ID: 12563111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ; Shimkin MB; Hsueh AJ
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxegol, an opioid antagonist with reduced CNS penetration: Mode-of-action and human relevance for rat testicular tumours.
    Andersson H; Mitchard T; Johnson N; Floettmann E
    Toxicol Appl Pharmacol; 2017 Aug; 329():85-95. PubMed ID: 28554659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
    Dirami G; Cooke BA
    Toxicol Appl Pharmacol; 1998 Jun; 150(2):393-401. PubMed ID: 9653071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats.
    Biegel LB; Hurtt ME; Frame SR; O'Connor JC; Cook JC
    Toxicol Sci; 2001 Mar; 60(1):44-55. PubMed ID: 11222872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of testicular interstitial macrophages in regulating testosterone release in hyperprolactinemia.
    Huang WJ; Yeh JY; Kan SF; Chang LS; Wang PS
    J Cell Biochem; 2003 Mar; 88(4):766-73. PubMed ID: 12577310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo exposure of young adult male rats to methoxychlor reduces serum testosterone levels and ex vivo Leydig cell testosterone formation and cholesterol side-chain cleavage activity.
    Murono EP; Derk RC; Akgul Y
    Reprod Toxicol; 2006 Feb; 21(2):148-53. PubMed ID: 16226009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signs of aging are apparent in the testis interstitium of Sprague Dawley rats at 6 months of age.
    Mendis-Handagama SM; Gelber SJ
    Tissue Cell; 1995 Dec; 27(6):689-99. PubMed ID: 8578559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats.
    Noriega NC; Howdeshell KL; Furr J; Lambright CR; Wilson VS; Gray LE
    Toxicol Sci; 2009 Sep; 111(1):163-78. PubMed ID: 19528224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leydig cell hyperplasia and adenomas in mice treated with finasteride, a 5 alpha-reductase inhibitor: a possible mechanism.
    Prahalada S; Majka JA; Soper KA; Nett TM; Bagdon WJ; Peter CP; Burek JD; MacDonald JS; van Zwieten MJ
    Fundam Appl Toxicol; 1994 Feb; 22(2):211-9. PubMed ID: 8005373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.